LensAR Incorporated
5
1
1
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.0%
1 terminated/withdrawn out of 5 trials
50.0%
-36.5% vs industry average
20%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery
Role: collaborator
Retrospective Analysis of the Time Elements for Different Workflow Scenarios During Femtosecond Laser-assisted Cataract Surgery (FLACS) From the Surgeon, Staff, and Patient Perspectives.
Role: lead
Feasibility Study of Laser Treatment of the Crystalline Lens to Correct Presbyopia
Role: lead
Prospective Clinical Trial of the LensAR Laser System
Role: lead
Laser Treatment of the Crystalline Lens
Role: lead
All 5 trials loaded